www.fdanews.com/articles/85175-biosystems-international-licences-northeastern-university-technology-for-biomarker-discovery
BIOSYSTEMS INTERNATIONAL LICENCES NORTHEASTERN UNIVERSITY TECHNOLOGY FOR BIOMARKER DISCOVERY
March 10, 2006
BioSystems International and Northeastern University (Boston MA) announce that
they have signed a Licence Agreement for The University's "Monoclonal antibody
based biomarker discovery and development platform." BioSystems International
(BSI) discovers and validates biomarkers through partnerships with pharmaceutical,
biotechnology and diagnostics companies and in-house research programs or academic
collaborations.
International
News Service